BackToBasic: Infliximab in Chronic Low Back Pain and Modic Changes
Condition: Low Back Pain Interventions: Drug: Biosimilar Infliximab; Other: Placebo Sponsors: Oslo University Hospital; Haukeland University Hospital; St. Olavs Hospital; University Hospital of North Norway; Vestre Viken Hospital Trust; Østfold Hospital Trust; Clinical Trial Unit (CTU), Oslo University Hospital; Diakonhjemmet Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Back Pain | Chronic Pain | Clinical Trials | Hospitals | Low Back Pain | Norway Health | Pain | Remicade